How Many Calories to Eat on Mounjaro

How many calories should you eat on Mounjaro is one of the most common questions from people starting tirzepatide for weight management. Most adults are guided towards a moderate deficit of around 500 to 600 kcal below their daily energy needs, though the right amount varies considerably by age, sex, weight and activity level. Because Mounjaro significantly reduces appetite, many people naturally eat less, making it important to ensure that smaller portions still meet nutritional requirements for protein, vitamins and minerals. This article explains calorie targets, dietary principles and how to get the most from treatment.

How many calories should you eat each day on Mounjaro?

Most adults on Mounjaro are guided towards a deficit of around 500 to 600 kcal per day below their total daily energy expenditure, with a personalised target calculated by a healthcare professional using validated equations.

Most adults using Mounjaro for weight management are guided towards a moderate calorie deficit, typically around 500 to 600 fewer kilocalories (kcal) per day than their estimated total daily energy expenditure, in line with NICE guidance on sustainable weight management. The right amount varies considerably between individuals, and the figures below are illustrative rather than universal. Calorie needs depend on age, sex, height, current weight, activity level and any underlying health conditions, and larger or more active adults may need considerably more than the lower end of any example range.

A registered dietitian or healthcare professional can calculate a personalised target using validated equations. In UK clinical practice, the Henry equations and the Schofield formula are both widely used to estimate basal metabolic rate, with an activity factor applied to give total daily energy expenditure.^[5][6]

NICE guidance on weight management emphasises that dietary changes should be sustainable and nutritionally adequate rather than focused on extreme restriction. For many adults, a daily intake somewhere in the region of 1,200 to 1,800 kcal (approximately 5,000 to 7,500 kJ) may represent a reasonable starting point, but this band is illustrative only and should always be adjusted to individual circumstances by a healthcare professional. Mounjaro (tirzepatide) is MHRA-authorised in the UK for both type 2 diabetes management and chronic weight management, and it is intended to work alongside, not instead of, dietary and lifestyle changes.^[7][8]

People with type 2 diabetes who are also taking insulin or a sulfonylurea should be aware that reducing calorie intake can increase the risk of hypoglycaemia (low blood sugar). If you are in this situation, discuss any planned dietary changes with your prescriber before making them, as your diabetes medication doses may need to be reviewed.

Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where Mounjaro is one option a prescriber may consider if it is clinically appropriate. Because Mounjaro significantly reduces appetite, many people find they naturally eat less without consciously counting calories. Tracking intake, at least initially, can help ensure that reduced eating still meets nutritional requirements, particularly for protein, vitamins and minerals.

Why does Mounjaro change your appetite and hunger levels?

Tirzepatide activates both GIP and GLP-1 receptors, slowing gastric emptying and increasing satiety signals in the brain, which substantially reduces appetite and portion sizes for most people.

Mounjaro reduces appetite and hunger because tirzepatide acts simultaneously on two gut hormone receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. According to the UK Mounjaro SmPC, this dual agonism produces combined effects on satiety signalling, insulin secretion and gastric emptying. These receptors are found not only in the pancreas but also in the brain, particularly in areas that regulate hunger and reward-related eating behaviour. By activating both pathways, tirzepatide slows gastric emptying (the rate at which food leaves the stomach), increases feelings of fullness after meals and reduces the drive to eat between meals.

The result for many people is a marked reduction in portion sizes, fewer cravings and a diminished interest in food overall. Some individuals describe this as food noise quietening, meaning the persistent background thoughts about eating become less intrusive. Individual responses vary, and the degree of appetite suppression differs between people.

It is worth understanding that these appetite changes are pharmacological rather than purely motivational. This means that even people who have previously struggled to reduce their food intake may find it considerably easier on Mounjaro. However, reduced appetite does not automatically lead to good nutritional choices. Eating less but still choosing nutrient-dense foods remains important, because the body's requirements for protein, fibre, calcium, iron and other micronutrients do not fall proportionally with calorie intake.

The slowing of gastric emptying can also affect the absorption of some oral medicines, including oral contraceptives.^[8][15] This is discussed further in the final section. If you take any regular oral medication, mention this to your prescriber when starting Mounjaro.

What does a healthy, balanced diet look like on Mounjaro?

A healthy diet on Mounjaro follows the NHS Eatwell Guide, with particular emphasis on adequate protein intake of around 1.2 to 1.6 g per kg of body weight daily to preserve muscle mass during weight loss.

A healthy diet on Mounjaro follows the same broad principles as general UK dietary guidance, centred on the NHS Eatwell Guide, but with particular attention to protein and micronutrient intake given the likelihood of eating smaller overall volumes of food. The Eatwell Guide recommends that meals are built around:

• Vegetables and fruit, aiming for at least five portions per day

• Starchy carbohydrates, preferably wholegrain versions such as brown rice, wholemeal bread and oats

• Protein sources, including lean meat, fish, eggs, beans, lentils and low-fat dairy

• Healthy fats, from sources such as oily fish, nuts, seeds and small amounts of unsaturated oils

Protein deserves particular emphasis on Mounjaro. Adequate protein intake helps preserve lean muscle mass during weight loss, which matters because rapid weight loss without sufficient protein can lead to muscle loss alongside fat loss. Current clinical nutrition guidance, including that from the British Dietetic Association, broadly suggests a target in the region of 1.2 to 1.6 grams of protein per kilogram of body weight per day during active weight loss, though the appropriate weight basis (actual, ideal or adjusted body weight) should be determined individually by a dietitian, particularly in people with obesity where using actual body weight may overestimate requirements. People with chronic kidney disease (CKD) should not increase protein intake without first seeking advice from a renal dietitian or their nephrology team, as higher protein intakes may not be appropriate in this group.

Because gastric emptying is slowed, some people find that large meals cause discomfort, bloating or nausea. Eating smaller, more frequent meals and chewing food thoroughly can help manage this. Foods that are high in fat or very rich tend to be less well tolerated by some individuals on Mounjaro. Staying well hydrated is also important, as reduced food intake can lower fluid consumption from food sources. A dietitian referral through your GP can provide personalised meal planning support, particularly if you have additional conditions such as type 2 diabetes or kidney disease.

Can eating too little on Mounjaro cause problems?

Eating too little on Mounjaro can cause nutritional deficiencies, muscle loss, fatigue and, in people taking insulin or a sulfonylurea, an increased risk of hypoglycaemia; intakes below 800 kcal per day require close medical supervision.

Eating too little on Mounjaro can cause nutritional deficiencies, muscle loss and fatigue, and in some cases may worsen gastrointestinal side effects rather than improve them. Because tirzepatide can suppress appetite substantially, some people inadvertently consume far fewer calories than their body needs to function well. Intakes consistently below around 800 kcal (approximately 3,350 kJ) per day are generally considered very low calorie diets and should only be followed under close medical supervision, as NICE guidance notes they carry risks including electrolyte imbalances, gallstone formation and loss of lean body mass.

People with type 2 diabetes who are taking insulin or a sulfonylurea face an additional risk: very low calorie intake can increase the likelihood of hypoglycaemia. If you are in this situation, speak to your prescriber before significantly reducing your food intake so that your medication can be reviewed.

Common signs that calorie intake may be too low include:

• Persistent fatigue or weakness that does not improve with rest

• Hair thinning or hair loss, which can occur with rapid or severe calorie restriction

• Dizziness or light-headedness, particularly on standing

• Difficulty concentrating or low mood

• Muscle cramps, which may indicate low electrolyte levels

These symptoms are non-specific and may have other causes, so if you experience any of them persistently or severely, contact your GP for assessment rather than simply increasing food intake without guidance.

Very low calorie intake does not necessarily accelerate weight loss in a beneficial way on Mounjaro. The medicine is designed to support a moderate, sustained deficit rather than extreme restriction. Eating too little can trigger the body's adaptive responses to perceived starvation, including a reduction in resting metabolic rate, which may make long-term weight maintenance harder. Suspected side effects from Mounjaro can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

How to get the most out of Mounjaro through diet and lifestyle

Mounjaro works best as part of a broader programme including a reduced-calorie diet, at least 150 minutes of moderate exercise per week and regular healthcare follow-up, consistent with the SURMOUNT trial design.

Getting the most out of Mounjaro requires treating the medicine as one component of a broader lifestyle programme rather than a standalone solution, which is consistent with how NICE frames weight management interventions. The SURMOUNT clinical trial programme, which supported Mounjaro's authorisation for weight management, included a reduced-calorie diet and increased physical activity as co-interventions alongside the medication, and the outcomes reflect that combined approach.^[21][22]

Practical steps that support the best outcomes include:

• Prioritising protein at every meal to protect muscle mass and support satiety

• Including regular physical activity, aiming for at least 150 minutes of moderate-intensity exercise per week as recommended by the UK Chief Medical Officers' Physical Activity Guidelines, incorporating both aerobic activity and resistance training where possible^[17][18]

• Eating mindfully and slowly, which helps the brain register fullness signals that may already be enhanced by the medication

• Limiting ultra-processed foods, alcohol and high-sugar drinks, which add calories with little nutritional benefit and may worsen nausea

• Keeping a food diary, at least initially, to ensure nutritional adequacy rather than simply tracking restriction

Regular follow-up with a healthcare professional is important throughout treatment. This allows dose adjustments to be made appropriately, side effects to be monitored and dietary support to be provided.

Regarding contraception: the UK Mounjaro SmPC (section 4.5) advises that women using oral contraceptives should add a barrier method for four weeks after starting Mounjaro and for four weeks after each dose increase, because slowed gastric emptying may reduce absorption of oral contraceptives during this period. Non-oral hormonal contraceptive methods are not expected to be affected. Regarding pregnancy and breastfeeding: the SmPC advises that Mounjaro is not recommended during pregnancy or breastfeeding. Women planning a pregnancy should discuss stopping Mounjaro with their prescriber in advance. If you become pregnant while taking Mounjaro, stop the medicine and contact your GP or midwife promptly. Speak to your GP or prescriber if you have any questions about contraception, pregnancy or breastfeeding while using Mounjaro.

Scientific References

1. Tirzepatide: discussion aid for healthcare professionals and patients.
2. Overweight and obesity management (NG246): Physical activity and diet.
3. Obesity update guideline draft – dietary calorie thresholds.
4. Calories and weight loss – Better Health.
5. Manual of Dietetic Practice Chapter 6.1: Nutritional requirements in clinical practice (Weekes CE, 2019).
6. Henry CJK. Basal metabolic rate studies in humans: measurement and development of new equations. Public Health Nutrition. 2005..
7. MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss.
8. Mounjaro (tirzepatide) Summary of Product Characteristics – EMC.
9. Mounjaro (tirzepatide) EPAR product information – EMA.
10. Low blood sugar (hypoglycaemia) – NHS.
11. The Eatwell Guide – NHS.
12. 5 A Day portion sizes – NHS.
13. Sport and exercise nutrition – British Dietetic Association.
14. Addressing sarcopenia – British Dietetic Association.
15. Tirzepatide – BNF (NICE).
16. Skelley JW et al. The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraceptives. 2024..
17. Physical activity guidelines: UK Chief Medical Officers' report. 2019..
18. UK Chief Medical Officers' physical activity guidelines (full guidance). 2019..
19. Physical activity guidelines for adults aged 19 to 64 – NHS.
20. Women on 'skinny jabs' must use effective contraception, MHRA urges in latest guidance.
21. Aronne LJ et al. SURMOUNT-4 randomized clinical trial. JAMA. 2024..
22. Galindo RJ et al. Weight changes with tirzepatide and concomitant medications: post hoc analysis of SURMOUNT-1, -3, and -4. JAMA Network Open. 2026..
23. Brain energy allocation is consistent with adaptive thermogenesis. Trends in Endocrinology and Metabolism. 2025..
24. Effect of time-restricted eating on metabolic adaptation in adults with severe obesity during early phase of weight loss. Journal of Human Nutrition and Dietetics. 2025..
25. Adaptive thermogenesis at the level of resting energy expenditure after diet alone or diet plus bariatric surgery. Obesity (Silver Spring). 2024..
26. Impact of nutrition education and low-protein dietary interventions on the incidence and progression of chronic kidney disease. Revista Medica de Chile. 2025..

Frequently Asked Questions